Search research articles
Contact Us
Filters
Showing results (71-80 of 703) with videos related to
Page
of 71
Sort By:
FEBS Open Bio
|
April 12, 2017
AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling
Yi Zhao, Yi Yang, Yunhua Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 20, 2012
[Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study]
Shun Lu, Li Zhang, Yongfeng Yu, et al.
Journal of Clinical Medicine
|
July 27, 2022
Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment
Yingjia Sun, Ziming Li, Hong Jian, et al.
Genes & Diseases
|
April 4, 2023
PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis
Qingyu Zhang, Shun Lu, Dongsheng Zhou, et al.
Frontiers in Pharmacology
|
October 15, 2019
The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials
Siyao Deng, Qinyan Yang, Xiaochen Shu, et al.
International Journal of Medical Sciences
|
February 25, 2021
Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing
Yongfeng Yu, Jie Qian, Lan Shen, et al.
Therapeutic Advances in Medical Oncology
|
December 25, 2023
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib
Li Zhang, Yongsheng Wang, Lizhu Lin, et al.
Pharmacogenomics
|
June 9, 2016
Economic analysis of ALK testing and crizotinib therapy for advanced non-small-cell lung cancer
Shun Lu, Jie Zhang, Ming Ye, et al.
International Journal of Clinical and Experimental Pathology
|
February 13, 2015
Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis
Yi Yang, Yi Zhao, Xinghao Ai, et al.
Nanomaterials (Basel, Switzerland)
|
November 12, 2025
MoS<sub>2</sub>-Based Composites for Electrochemical Detection of Heavy Metal Ions: A Review
Baizun Cheng, Hongdan Wang, Shouqin Xiang, et al.
Page
of 71
Search research articles
Search
Showing results (71-80 of 703) with videos related to
Sort By:
Page
of 71
FEBS Open Bio
|
April 12, 2017
AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling
Yi Zhao, Yi Yang, Yunhua Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 20, 2012
[Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study]
Shun Lu, Li Zhang, Yongfeng Yu, et al.
Journal of Clinical Medicine
|
July 27, 2022
Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment
Yingjia Sun, Ziming Li, Hong Jian, et al.
Genes & Diseases
|
April 4, 2023
PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis
Qingyu Zhang, Shun Lu, Dongsheng Zhou, et al.
Frontiers in Pharmacology
|
October 15, 2019
The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials
Siyao Deng, Qinyan Yang, Xiaochen Shu, et al.
International Journal of Medical Sciences
|
February 25, 2021
Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing
Yongfeng Yu, Jie Qian, Lan Shen, et al.
Therapeutic Advances in Medical Oncology
|
December 25, 2023
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib
Li Zhang, Yongsheng Wang, Lizhu Lin, et al.
Pharmacogenomics
|
June 9, 2016
Economic analysis of ALK testing and crizotinib therapy for advanced non-small-cell lung cancer
Shun Lu, Jie Zhang, Ming Ye, et al.
International Journal of Clinical and Experimental Pathology
|
February 13, 2015
Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis
Yi Yang, Yi Zhao, Xinghao Ai, et al.
Nanomaterials (Basel, Switzerland)
|
November 12, 2025
MoS<sub>2</sub>-Based Composites for Electrochemical Detection of Heavy Metal Ions: A Review
Baizun Cheng, Hongdan Wang, Shouqin Xiang, et al.
Page
of 71